Drug Withdrawn - Vioxx, A Perspective After National Arthritis Meeting

Title: Drug Withdrawn - Vioxx, A Perspective After National Arthritis MeetingCategory: Doctor's&Expert's views on SymptomsCreated: 11/1/2004 12:00:00 AMLast Editorial Review: 6/13/2018 2:55:10 PM
Source: MedicineNet Arthritis General - Category: Rheumatology Source Type: news

Related Links:

CONCLUSIONS. : These results are encouraging in terms of the immunomodulating effect of this Peruvian medicinal plant and justify the continuation of their study for a potential clinical application. PMID: 29924278 [PubMed - in process]
Source: Revista Peruana de Medicina de Experimental y Salud Publica - Category: International Medicine & Public Health Tags: Rev Peru Med Exp Salud Publica Source Type: research
NEW YORK (Reuters Health)—Disease-modifying antirheumatic drugs (DMARDs) reduce the risk of developing rheumatoid arthritis (RA) in patients with early undifferentiated arthritis, researchers from France report. Several studies have suggested that conventional or biological DMARDs might interfere with the pathogenic process and prevent more established forms of RA, but it remains unclear whether these drugs are... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: DMARDs & Immunosuppressives Drug Updates Rheumatoid Arthritis biological DMARDs (bDMARDs) Bruno Fautrel conventional DMARDs (csDMARDS) Disease-modifying antirheumatic drugs (DMARDs) early undifferentiated arthritis Institut Pierre Louis d' Source Type: research
On Sept. 23–25, the ACR will once again holds its annual Advocates for Arthritis fly-in event in Washington, D.C. Held in conjunction with the ACR’s Advocacy 101 course, these events are a great way for members to learn about and participate in advocacy that focuses on issues important to the practice of rheumatology. “These events... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: Legislation & Advocacy Professional Topics 2018 Advocates for Arthritis Advocacy 101 course fly-in Source Type: research
Amy B. Scher’s “This Is How I Save My Life” is the true story of a fiery young woman diagnosed with late-stage, chronic Lyme disease whose journey takes her from near-death in California to a trip around the world in search of her ultimate salvation. This excerpt coincides with the book’s release in paperback from Gallery Books, an imprint CBS sister company Simon &Schuster. I am twenty-eight years old when I arrive in magnificent India. I am here with my parents, an updated vaccine record, and a visa, searching for something I cannot find at home: a cure. In a tiny hospital on the outskirts of ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health Simon and Schuster Source Type: news
Conclusion: The mixed-type LMN patients had a higher blood pressure, higher BUN and positive LE cell than those of the pure-type LMN patients. Hypertension at initial presentation can be a predictor of proliferative lesion in renal pathology. However, a proliferative lesion accompanied with LMN does not affect renal outcomes. With similar renal outcomes, the immunosuppressive with low adverse effects may be considered as a preferable treatment. PMID: 29916235 [PubMed - in process]
Source: Journal of the Medical Association of Thailand = Chotmaihet thangphaet - Category: General Medicine Tags: J Med Assoc Thai Source Type: research
At the University of Cambridge, scientists have developed a method of monitoring small changes in joints of patients living with osteoarthritis. The capability should give clinical researchers and physicians treating patients a new tool to better und...
Source: Medgadget - Category: Medical Devices Authors: Tags: Medicine Orthopedic Surgery Radiology Source Type: blogs
Condition:   Arthritis, Psoriatic Intervention:   Procedure: Arthroscopy Sponsor:   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
The most common tick-borne illness in the U.S. (30,000+ new cases a year), Lyme disease produces a wide range of symptoms ranging from fever and rash to arthritis and paralysis. Thanks to biotech, genome sequencing and precision medicine, prevention, early detection and treatment are now possible.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
THURSDAY, June 21, 2018 -- The European League Against Rheumatism has released recommendations -- published in the June issue of the Annals of the Rheumatic Diseases -- for health professionals to use in approaching pain management in inflammatory...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
In conclusion, the results of the current study demonstrates that the repression of Syvn1 expression induces the conversion of neurotoxic KYN to neuroprotective KYNA in a CLP‑induced mouse model of sepsis, and that Syvn1 is a potential novel target for the treatment of SAE. PMID: 29916549 [PubMed - as supplied by publisher]
Source: Molecular Medicine Reports - Category: Molecular Biology Tags: Mol Med Rep Source Type: research
More News: Arthritis | Rheumatology | Vioxx